Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers

被引：0
|
作者：
Gaia, S [1 ]
Marzano, A [1 ]
Ciardo, V [1 ]
Gentilcore, E [1 ]
Lagget, M [1 ]
Smedile, A [1 ]
Rizzetto, M [1 ]
机构：
[1] Molinette Mauriziano Hosp, Dept Gastroenterol, Turin, Italy
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80111-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
112
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] Lamivudine (LAM) plus HBIg combination therapy compared to HBIg or no therapy in preventing hepatitis B (HBV) recurrence after liver transplantation (LT)
    Andreone, P
    Grazi, GL
    Gramenzi, A
    Cursaro, C
    Biselli, M
    Caraceni, P
    Morelli, MC
    Sama, C
    Iovine, E
    Del Gaudio, M
    Bellusci, R
    Mazziotti, A
    Cavallari, A
    Bernardi, M
    JOURNAL OF HEPATOLOGY, 2000, 32 : 51 - 51
  • [2] Efficacy of combined lamivudine (LAM) and hepatitis B immunoglobulin (HBIg) for the prevention of hepatitis B recurrence after liver transplantation (LT): Birmingham experience.
    Bizollon, T
    Gunson, B
    Dudley, T
    Haydon, G
    Mutimer, D
    LIVER TRANSPLANTATION, 2006, 12 (05) : C20 - C20
  • [3] Combined short-term hepatitis B immunoglobulin (HBIG) and long-term lamivudine (LAM) versus HBIG monotherapy as hepatitis B virus (HBV) prophylaxis in liver transplant recipients
    Terrault, NA
    Wright, TL
    Roberts, JP
    Ascher, NL
    HEPATOLOGY, 1998, 28 (04) : 389A - 389A
  • [4] Prophylaxis of hepatitis B reinfection after liver transplantation with HBIg and lamivudine.
    Rosenau, J
    Bahr, MJ
    Tillmann, HL
    Klempnauer, J
    Manns, MP
    Boeker, KH
    GASTROENTEROLOGY, 2000, 118 (04) : A1483 - A1483
  • [5] Management and outcome of lamivudine(LAM)-resistant hepatitis B virus (HBV) infection after liver transplantation (LT).
    Shields, PL
    Ling, R
    Harrison, T
    Boxall, E
    Elias, E
    Mutimer, DJ
    HEPATOLOGY, 1997, 26 (04) : 527 - 527
  • [6] Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immunoglobulin prophylaxis
    Zheng, SS
    Chen, YM
    Liang, TB
    Lu, AW
    Wang, WL
    Shen, Y
    Zhang, M
    LIVER TRANSPLANTATION, 2006, 12 (02) : 253 - 258
  • [7] Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants
    Marzano, A
    Lampertico, P
    Mazzaferro, V
    Carenzi, S
    Vigano, M
    Romito, R
    Pulvirenti, A
    Franchello, A
    Colombo, M
    Salizzoni, M
    Rizzetto, M
    LIVER TRANSPLANTATION, 2005, 11 (05) : 532 - 538
  • [8] Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis
    Rao, Wensheng
    Wu, Xuejie
    Xiu, Dianrong
    TRANSPLANT INTERNATIONAL, 2009, 22 (04) : 387 - 394
  • [9] A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation
    Buti, M
    Mas, A
    Prieto, M
    Casafont, F
    Gonzalez, A
    Miras, M
    Herrero, JI
    Jardí, R
    de Castro, EC
    García-Rey, C
    JOURNAL OF HEPATOLOGY, 2003, 38 (06) : 811 - 817
  • [10] Factors associated with viral breakthrough in lamivudine monotherapy for the prophylaxis of hepatitis B virus recurrence after liver transplantation
    Chan, HLY
    Chui, AKK
    Lau, JWY
    Chan, FKL
    Wong, ML
    Tse, CH
    Rao, NT
    Wong, J
    Sung, JJY
    GASTROENTEROLOGY, 2002, 123 (01) : 82 - 82
12345